Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.
DA Costa Machado AK, Machado CB, DE Pinho Pessoa FMC, Barreto IV, Gadelha RB, DE Sousa Oliveira D, Ribeiro RM, Lopes GS, DE Moraesfilho MO, DE Moraes MEA, Khayat AS, Moreira-Nunes CA.
DA Costa Machado AK, et al. Among authors: machado cb.
Cancer Diagn Progn. 2024 Jan 3;4(1):9-24. doi: 10.21873/cdp.10279. eCollection 2024 Jan-Feb.
Cancer Diagn Progn. 2024.
PMID: 38173664
Free PMC article.
Review.